Think of Vowst as Similar to Rebyota
July 2023
New Rx Vowst will be the first ORAL fecal microbiota product FDA-approved for preventing C. diff recurrence in adults.
It comes on the heels of FDA approval of Rebyota...afecal microbiota enema. Other fecal transplant products are investigational.
Recall that fecal microbiota therapies are prepped using stool samples from donors tested for infectious diseases (COVID-19, HIV, etc)...and screened for recent antibiotic use, diarrhea, etc.
Practical advice for a better career, with unlimited access to CE
Hospital Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote